Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Koh

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study)Hiroaki Akamatsu, Yasuhiro Koh, Isamu Okamoto, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2002
Enhanced antitumor activities of TZT-1027 against TNF-alpha or IL-6 secreting Lewis lung carcinoma in vivoTsugitaka Natsume, Yasuhiro Koh, Motohiro Kobayashi, et al.
International Journal of Oncology|June 7, 2003
Differential gene expression profiles and identification of the genes relevant to clinicopathologic factors in colorectal cancer selected by cDNA array method in combination with principal component analysisTakuya Tsunoda, Yasuhiro Koh, Fumiaki Koizumi, et al.
Clinical Lung Cancer|September 11, 2018
Osimertinib With Ramucirumab in EGFR-mutated, T790M-positive Patients With Progression During EGFR-TKI Therapy: Phase Ib StudyHiroaki Akamatsu, Yasuhiro Koh, Yuichi Ozawa, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 12, 2013
Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based systemMasaru Watanabe, Yuri Uehara, Namiko Yamashita, et al.
Anticancer Research|June 13, 2014
Identification of metabolic signatures associated with erlotinib resistance of non-small cell lung cancer cellsMasakuni Serizawa, Masatoshi Kusuhara, Vincent Zangiacomi, et al.
Journal of Virology|September 28, 2012
Loss of the protease dimerization inhibition activity of tipranavir (TPV) and its association with the acquisition of resistance to TPV by HIV-1Manabu Aoki, Matthew L Danish, Hiromi Aoki-Ogata, et al.
Cancer Genetics|July 22, 2015
The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissuesMasakuni Serizawa, Tomoya Yokota, Ayumu Hosokawa, et al.
Biological & Pharmaceutical Bulletin|September 2, 2009
P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell linesHiromi Fujimoto, Maiko Higuchi, Hiroshi Watanabe, et al.
Cancer Science|September 12, 2003
Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivoTsugitaka Natsume, Jun-ichi Watanabe, Yasuhiro Koh, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study)Hiroaki Akamatsu, Yasuhiro Koh, Isamu Okamoto, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2002
Enhanced antitumor activities of TZT-1027 against TNF-alpha or IL-6 secreting Lewis lung carcinoma in vivoTsugitaka Natsume, Yasuhiro Koh, Motohiro Kobayashi, et al.
International Journal of Oncology|June 7, 2003
Differential gene expression profiles and identification of the genes relevant to clinicopathologic factors in colorectal cancer selected by cDNA array method in combination with principal component analysisTakuya Tsunoda, Yasuhiro Koh, Fumiaki Koizumi, et al.
Clinical Lung Cancer|September 11, 2018
Osimertinib With Ramucirumab in EGFR-mutated, T790M-positive Patients With Progression During EGFR-TKI Therapy: Phase Ib StudyHiroaki Akamatsu, Yasuhiro Koh, Yuichi Ozawa, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 12, 2013
Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based systemMasaru Watanabe, Yuri Uehara, Namiko Yamashita, et al.
Anticancer Research|June 13, 2014
Identification of metabolic signatures associated with erlotinib resistance of non-small cell lung cancer cellsMasakuni Serizawa, Masatoshi Kusuhara, Vincent Zangiacomi, et al.
Journal of Virology|September 28, 2012
Loss of the protease dimerization inhibition activity of tipranavir (TPV) and its association with the acquisition of resistance to TPV by HIV-1Manabu Aoki, Matthew L Danish, Hiromi Aoki-Ogata, et al.
Cancer Genetics|July 22, 2015
The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissuesMasakuni Serizawa, Tomoya Yokota, Ayumu Hosokawa, et al.
Biological & Pharmaceutical Bulletin|September 2, 2009
P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell linesHiromi Fujimoto, Maiko Higuchi, Hiroshi Watanabe, et al.
Cancer Science|September 12, 2003
Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivoTsugitaka Natsume, Jun-ichi Watanabe, Yasuhiro Koh, et al.
Pageof 15